Tower Research Capital (TRC)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.6K | Buy |
|
|||||
|
2025
Q1 | $13.3K | Buy |
|
|||||
|
2024
Q4 | $24.3K | Buy |
|
|||||
|
2024
Q3 | $24.1K | Sell |
|
|||||
|
2024
Q2 | $72.5K | Buy |
|
|||||
|
2024
Q1 | $60.2K | Sell |
|
|||||
|
2023
Q4 | $57K | Sell |
|
|||||
|
2023
Q3 | $86.6K | Buy |
|
|||||
|
2023
Q2 | $118K | Buy |
|
|||||
|
2023
Q1 | $56K | Buy |
|
|||||
|
2022
Q4 | $83K | Sell |
|
|||||
|
2022
Q3 | $1.21M | Buy |
|
|||||
|
2022
Q2 | $183K | Sell |
|
|||||
|
2022
Q1 | $482K | Buy |
|
|||||
|
2021
Q4 | $231K | Buy |
|
|||||
|
2021
Q3 | $217K | Buy |
|
|||||
|
2021
Q2 | $281K | Sell |
|
|||||
|
2021
Q1 | $1.9M | Buy |
|
|||||
|
2020
Q4 | $656K | Buy |
|
|||||
|
2020
Q3 | $113K | Sell |
|
|||||
|
2020
Q2 | $416K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $121K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $0 | Sell |
|
|||||
|
2018
Q3 | $96K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $39K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $2K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $6K | Buy |
|
|||||
|
2015
Q4 | $0 | Sell |
|
|||||
|
2015
Q3 | $1K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $1K | Sell |
|
|||||
|
2014
Q3 | $7K | Buy |
|
|||||
|
2014
Q2 | $4K | Buy |
|
|||||
|
2014
Q1 | $6K | Sell |
|
|||||
|
2013
Q4 | $66K | Buy |
|